Look beyond the plasma cells in immunocompromised patients
Romain Lécuyer(Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers), Martin Gauthier(Institut universitaire du cancer de Toulouse Oncopole), Imène Guelib(Centre Hospitalier Jean-Rostand), L. Caudrelier(Groupe Cahors (France)), Barnabé Daniau(Groupe Cahors (France)), Nathalie Wilhelm(Groupe Cahors (France))
Cited by 0
Related Papers
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
|Blood Advances|2021|51
Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease
|CHEST Journal|2024|49
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of <i>Pneumocystis jirovecii</i> Pneumonia
|The Journal of Infectious Diseases|2021|36
Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective study
|Annals of Intensive Care|2025|4
Listeria Endophthalmitis cured with Linezolid in an Immunocompetent Farmer Woman: Hazard of a Sweep of a Cow Tail
|Open Forum Infectious Diseases|2019|3